Jefferies Group LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 136 filers reported holding NEKTAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2022$99,560
-95.1%
26,200
-93.0%
0.00%
-92.3%
Q1 2022$2,021,067
-11.9%
374,966
+120.9%
0.01%
-7.1%
Q4 2021$2,292,998
+568.1%
169,726
+748.6%
0.01%
+600.0%
Q2 2021$343,200
-69.3%
20,000
-61.4%
0.00%
-77.8%
Q4 2019$1,119,000
-88.5%
51,835
-81.1%
0.01%
-87.3%
Q2 2019$9,761,000
+3277.5%
274,319
+3089.8%
0.07%
+3450.0%
Q1 2019$289,000
-76.9%
8,600
-77.4%
0.00%
-80.0%
Q4 2018$1,252,000
-73.0%
38,100
-50.0%
0.01%
-66.7%
Q3 2018$4,645,000
+221.5%
76,192
+157.5%
0.03%
+275.0%
Q2 2018$1,445,000
+21.0%
29,585
+47.9%
0.01%
+33.3%
Q4 2017$1,194,000
-15.3%
20,000
-80.5%
0.01%
-25.0%
Q1 2016$1,410,000
+464.0%
102,600
+593.2%
0.01%
+700.0%
Q4 2015$250,000
-68.6%
14,800
-79.6%
0.00%
-75.0%
Q3 2015$795,000
+2641.4%
72,496
+3052.0%
0.00%
Q2 2015$29,000
-96.9%
2,300
-97.3%
0.00%
-100.0%
Q1 2015$941,000
+19.3%
85,500
+67.9%
0.01%0.0%
Q4 2014$789,000
+124.1%
50,916
+85.4%
0.01%
+66.7%
Q2 2014$352,000
-63.6%
27,467
-70.4%
0.00%
-70.0%
Q3 2013$968,000
-77.7%
92,645
-75.3%
0.01%
-78.7%
Q2 2013$4,339,000375,6680.05%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2013
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders